Insilico Medicine, an artificial intelligence company specialized in the application of learning for target identification, drug discovery and aging research, has completed a strategic round of funding led by WuXi AppTec’s Corporate Venture Fund. The strategic investment was conditional upon the successful experimental validation of Insilico Medicine’s Generative Adversarial Networks (GAN) and Reinforcement Learning (RL)-based drug discovery pipeline and is intended to closely integr...